| 1 | differ | 11,680 |
| 2 | detract | 25 |
| 3 | over-treat | 2 |
| 4 | 3-propenalyl | 1 |
| 5 | 5-fluorouracil-treated | 1 |
| 6 | affected.a | 1 |
| 7 | anneals | 1 |
| 8 | assessed.3 | 1 |
| 9 | cancer-type-dependent | 1 |
| 10 | casp-9 | 1 |
| 11 | changed.5 | 1 |
| 12 | conterbalanced | 1 |
| 13 | couldalso | 1 |
| 14 | cross-in | 1 |
| 15 | d-dimer-declined | 1 |
| 16 | dcr1 | 1 |
| 17 | decurarized | 1 |
| 18 | deforming-structures | 1 |
| 19 | diriment | 1 |
| 20 | dishonourable | 1 |
| 21 | dyalipidémiques | 1 |
| 22 | eixted | 1 |
| 23 | entubated | 1 |
| 24 | full-proof | 1 |
| 25 | genotype×diagnosis | 1 |
| 26 | groupable | 1 |
| 27 | gst-irf3 | 1 |
| 28 | hpv-2 | 1 |
| 29 | ibdq-emotional | 1 |
| 30 | kcnn2/sk2/k | 1 |
| 31 | nlrp3/asc | 1 |
| 32 | nothofagus | 1 |
| 33 | ntcas-ssris | 1 |
| 34 | nvp-bez235/azd6244 | 1 |
| 35 | oe21 | 1 |
| 36 | overcooked | 1 |
| 37 | participants.beta-blockers | 1 |
| 38 | pon2-h114q | 1 |
| 39 | post-savr | 1 |
| 40 | pre-detected | 1 |
| 41 | procrastinate | 1 |
| 42 | refluent | 1 |
| 43 | riskless | 1 |
| 44 | sandwiching | 1 |
| 45 | seeking-help | 1 |
| 46 | stnrfii | 1 |
| 47 | sufficing | 1 |
| 48 | thermospermine | 1 |
| 49 | typeable | 1 |
| 50 | universally-accepted | 1 |
| 51 | vocalize | 1 |
| 52 | yell | 1 |
| 53 | β-neurexins | 1 |
| 54 | γ-crystallin | 1 |
| 1 | 3-propenalyl | 1 |
| 2 | 5-fluorouracil-treated | 1 |
| 3 | affected.a | 1 |
| 4 | anneals | 1 |
| 5 | assessed.3 | 1 |
| 6 | cancer-type-dependent | 1 |
| 7 | casp-9 | 1 |
| 8 | changed.5 | 1 |
| 9 | conterbalanced | 1 |
| 10 | couldalso | 1 |
| 11 | cross-in | 1 |
| 12 | d-dimer-declined | 1 |
| 13 | dcr1 | 1 |
| 14 | decurarized | 1 |
| 15 | deforming-structures | 1 |
| 16 | detract | 25 |
| 17 | differ | 11,680 |
| 18 | diriment | 1 |
| 19 | dishonourable | 1 |
| 20 | dyalipidémiques | 1 |
| 21 | eixted | 1 |
| 22 | entubated | 1 |
| 23 | full-proof | 1 |
| 24 | genotype×diagnosis | 1 |
| 25 | groupable | 1 |
| 26 | gst-irf3 | 1 |
| 27 | hpv-2 | 1 |
| 28 | ibdq-emotional | 1 |
| 29 | kcnn2/sk2/k | 1 |
| 30 | nlrp3/asc | 1 |
| 31 | nothofagus | 1 |
| 32 | ntcas-ssris | 1 |
| 33 | nvp-bez235/azd6244 | 1 |
| 34 | oe21 | 1 |
| 35 | over-treat | 2 |
| 36 | overcooked | 1 |
| 37 | participants.beta-blockers | 1 |
| 38 | pon2-h114q | 1 |
| 39 | post-savr | 1 |
| 40 | pre-detected | 1 |
| 41 | procrastinate | 1 |
| 42 | refluent | 1 |
| 43 | riskless | 1 |
| 44 | sandwiching | 1 |
| 45 | seeking-help | 1 |
| 46 | stnrfii | 1 |
| 47 | sufficing | 1 |
| 48 | thermospermine | 1 |
| 49 | typeable | 1 |
| 50 | universally-accepted | 1 |
| 51 | vocalize | 1 |
| 52 | yell | 1 |
| 53 | β-neurexins | 1 |
| 54 | γ-crystallin | 1 |
| 1 | oe21 | 1 |
| 2 | dcr1 | 1 |
| 3 | hpv-2 | 1 |
| 4 | assessed.3 | 1 |
| 5 | gst-irf3 | 1 |
| 6 | nvp-bez235/azd6244 | 1 |
| 7 | changed.5 | 1 |
| 8 | casp-9 | 1 |
| 9 | affected.a | 1 |
| 10 | nlrp3/asc | 1 |
| 11 | conterbalanced | 1 |
| 12 | overcooked | 1 |
| 13 | d-dimer-declined | 1 |
| 14 | entubated | 1 |
| 15 | 5-fluorouracil-treated | 1 |
| 16 | pre-detected | 1 |
| 17 | universally-accepted | 1 |
| 18 | eixted | 1 |
| 19 | decurarized | 1 |
| 20 | typeable | 1 |
| 21 | groupable | 1 |
| 22 | dishonourable | 1 |
| 23 | thermospermine | 1 |
| 24 | procrastinate | 1 |
| 25 | vocalize | 1 |
| 26 | full-proof | 1 |
| 27 | sufficing | 1 |
| 28 | sandwiching | 1 |
| 29 | stnrfii | 1 |
| 30 | kcnn2/sk2/k | 1 |
| 31 | ibdq-emotional | 1 |
| 32 | yell | 1 |
| 33 | 3-propenalyl | 1 |
| 34 | cross-in | 1 |
| 35 | γ-crystallin | 1 |
| 36 | couldalso | 1 |
| 37 | seeking-help | 1 |
| 38 | pon2-h114q | 1 |
| 39 | differ | 11,680 |
| 40 | post-savr | 1 |
| 41 | deforming-structures | 1 |
| 42 | dyalipidémiques | 1 |
| 43 | ntcas-ssris | 1 |
| 44 | genotype×diagnosis | 1 |
| 45 | anneals | 1 |
| 46 | β-neurexins | 1 |
| 47 | participants.beta-blockers | 1 |
| 48 | riskless | 1 |
| 49 | nothofagus | 1 |
| 50 | over-treat | 2 |
| 51 | detract | 25 |
| 52 | cancer-type-dependent | 1 |
| 53 | diriment | 1 |
| 54 | refluent | 1 |